darolutamide
bayer
['aramis', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'darolutamide', 'bayer']
long-term safety &amp; tolerability of darolutamide and duration of rx in pts with nmcrpc from the aramis rollover study median duration of rx: 2.8 yrs 30.1% received darolutamide &gt;4 yrs, 12.8% &gt;5 yrs teaes of interest: fatigue (14.9%), htn (10.3%) #gu23 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday